Reducing Heterogeneity in OA Clinical Trials: Data from a Phase 2 Study of SM04690, a Novel, Intra-Articular, Wnt Pathway Inhibitor in Knee Osteoarthritis

被引：0
|
作者：
Conaghan, Philip G. [1 ]
DiFrancesco, Anita [2 ]
Swearingen, Christopher J. [2 ]
Kennedy, Sarah [2 ]
Simsek, Ismail [2 ]
Tambiah, Jeymi [2 ]
Yazici, Yusuf [2 ]
机构：
[1] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[2] Samumed LLC, San Diego, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1201
引用
收藏
页数：2
相关论文
共 50 条
  • [1] RESULTS FROM A PHASE 2B TRIAL OF SM04690, A NOVEL INTRA-ARTICULAR WNT PATHWAY INHIBITOR FOR THE TREATMENT OF KNEE OSTEOARTHRITIS
    Yazici, Y.
    Mcalindon, T.
    Gibofsky, A.
    Lane, N.
    Lattermann, C.
    Skrepnik, N.
    Swearingen, C.
    Difrancesco, A.
    Tambiah, J.
    Hochberg, M.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S183 - S184
  • [2] EFFICACY AND SAFETY FROM A PHASE 2B TRIAL OF SM04690, A NOVEL, INTRA-ARTICULAR, WNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
    Yazici, Y.
    McAlindon, T. E.
    Gibofsky, A.
    Lane, N. E.
    Latterman, C.
    Skrepnik, N.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J. R.
    Hochberg, M. C.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S503 - S503
  • [3] EFFICACY AND SAFETY FROM A PHASE 2B TRIAL OF SM04690, A NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
    Yazici, Yusuf
    McAlindon, Timothy
    Gibofsky, Allan
    Lane, Nancy
    Latterman, Christian
    Skrepnik, Nebojsa
    Swearingen, Chris
    DiFrancesco, Anita
    Tambiah, Jeyanesh
    Hochberg, Marc
    Grifman, Mirta
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S12 - S12
  • [4] EFFICACY AND SAFETY FROM A PHASE 2B TRIAL OF SM04690, A NOVEL INTRA-ARTICULAR WNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
    Yazici, Yusuf
    Mcalindon, Timothy
    Gibofsky, Allan
    Lane, Nancy
    Lattermann, Christian
    Skrepnik, Nebojsa
    Swearingen, Christopher
    Difrancesco, Anita
    Tambiah, Jeyanesh
    Hochberg, Marc
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 519 - 519
  • [5] RESULTS FROM A 52-WEEK, PHASE 2A STUDY OF AN INTRA- ARTICULAR, WNT PATHWAY INHIBITOR, SM04690, FOR KNEE OSTEOARTHRITIS
    Yazici, Y.
    Mcalindon, T.
    Gibofsky, A.
    Lane, N.
    Clauw, D.
    Swearingen, C.
    Difrancesco, A.
    Tambiah, J.
    Hochberg, M.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S51 - S52
  • [6] Discovery of an Intra-Articular Injection Small Molecule Inhibitor of the Wnt Pathway (SM04690) As a Potential Disease Modifying Treatment for Knee Osteoarthritis
    Barroga, Charlene
    Hu, Yong
    Deshmukh, Vishal
    Hood, John
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [7] COMPARISON OF INTRA-ARTICULAR SHAM AND VEHICLE INJECTIONS FROM A PHASE 2B TRIAL OF SM04690, A SMALL-MOLECULE WNT PATHWAY INHIBITOR FOR KNEE OSTEOARTHRITIS
    Yazici, Yusuf
    Tambiah, Jeyanesh
    Swearingen, Christopher
    Kennedy, Sarah
    Strand, Vibeke
    Cole, Brian
    Hochberg, Marc
    Bannuru, Raveendhara
    Mcalindon, Timothy
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 494 - 494
  • [8] Results from a 52 Week Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Wnt Pathway Inhibitor (SM04690) for the Treatment of Knee Osteoarthritis
    Yazici, Yusuf
    McAlindon, Timothy E.
    Gibofsky, Allan
    Lane, Nancy E.
    Clauw, Daniel J.
    Armas, Eddie
    Skrepnik, Nebojsa
    Swearingen, Christopher J.
    DiFrancesco, Anita
    Tambiah, Jeymi
    Hochberg, Marc
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [9] RESULTS FROM A 52-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS
    Yazici, Y.
    McAlindon, T. E.
    Gibofsky, A.
    Lane, N. E.
    Clauw, D. J.
    Jones, M. H.
    Bergfeld, J.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J. R.
    Hochberg, M.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 : S293 - S294
  • [10] PROSPECTIVE COMPARISON OF INTRA-ARTICULAR SHAM VS. PLACEBO INJECTIONS: DATA FROM A RANDOMIZED, CONTROLLED PHASE 2B TRIAL OF SM04690, A WNT PATHWAY INHIBITOR FOR KNEE OSTEOARTHRITIS
    Yazici, Y.
    Tambiah, J.
    Swearingen, C.
    Kennedy, S.
    Strand, V.
    Cole, B.
    Hochberg, M.
    Bannuru, R.
    McAlindon, T.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S519 - S520
12345